AAV
Gene Therapy
TESSA
Viral Vectors
Minaris’ TESSA® platform uses a self-silencing helper adenoviral vector to block late structural protein expression, enabling a scalable, cost-effective and clean AAV manufacturing process without adenoviral contamination.
